RACIAL AND ETHNIC DISPARITIES IN MEETING MTM ELIGIBILITY CRITERIA BASED ON STAR RATINGS COMPARED TO MMA

Author(s)

Wang J1, Qiao Y2, Spivey C2, Shih YT3, Wan J4, Kuhle J5, Dagogo-Jack S4, Cushman W4, Chisholm-Burns M2
1The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA, 2The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA, 3The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 4The University of Tennessee Health Science Center College of Medicine, Memphis, TN, USA, 5Pharmacy Quality Alliance, Springfield, VA, USA

OBJECTIVES: Racial and ethnic disparities were found in meeting Medication Therapy Management (MTM) eligibility criteria implemented under Medicare Modernization Act (MMA). Therefore, the objective is to examine whether an alternative MTM eligibility standard based on Medicare Part D Star Ratings system can reduce racial and ethnic disparities. METHODS: The study analyzed 2012-2013 Medicare claims data for 3 million beneficiaries. Patients were considered MTM-eligible if they had any issues with measures of medication utilizations in Star-Ratings. Logistic regression and Blinder-Oaxaca approach were used to test disparities in meeting eligibility criteria of Star-Ratings across racial/ethnic groups. Multinomial logistic regression was used to examine whether there was disparity reduction by comparing individuals who were MTM-eligible under MMA but not Star-Ratings and those who were MTM-eligible under Star-Ratings but not MMA. Disease-specific analysis was conducted for each of the top ten MTM-targeted chronic conditions. Main and sensitivity analyses were conducted for MMA-based thresholds (used in 2009 and 2013 by Part D plans, and proposed for 2015 by the Centers for Medicare & Medicaid Services) and Star-Ratings measure combinations. RESULTS: Adjusted odds ratios to non-Hispanic Whites (Whites) were 1.394 (95% Confidence Interval (CI)=1.375-1.414) for non-Hispanic Blacks (Blacks) and 1.197 (95% CI=1.176-1.218) for Hispanics, indicating likelihood of MTM eligibility under Star-Ratings 39.4% higher among Blacks and 19.7% higher among Hispanics than Whites. Disparities were not completely explained by difference in patient characteristics based on Blinder-Oaxaca approach. Multinomial logistic regression found significant racial and ethnic disparity reduction in main analysis, e.g., Black-White and Hispanic-White disparities in MTM eligibility were reduced by 55.1% (Relative Risk Ratios (RRR)=0.449, 95% CI=0.434-0.465), and 45.6% (RRR=0.544, 95% CI=0.521-0.569), respectively, when using Star-Ratings compared to 2013 MMA criteria. Similar patterns were found in sensitivity and disease-specific analyses. CONCLUSIONS: Star-Ratings criteria would reduce racial and ethnic disparities in the general Medicare population and those with specific chronic conditions.

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PHS126

Topic

Health Policy & Regulatory

Topic Subcategory

Health Disparities & Equity

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×